False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan

Journal of Endocrinological Investigation

Volumn 21, Issue 11, 1998, Pages 779-783

  Letizia, C ^a,b   De Toma, G ^a   Massa, R ^a   Corsi, A ^a   Caliumi, C ^a   Subioli, S ^a   D'Erasmo, E ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

Adrenocortical adenoma; False positive result; I 123 metaiodobenzylguanidine scintigraphy

Indexed keywords

(3 IODOBENZYL)GUANIDINE; IODINE 123; RADIOPHARMACEUTICAL AGENT;

ADRENAL CORTEX ADENOMA; ADRENAL SCINTISCANNING; ADULT; ARTICLE; CASE REPORT; DIAGNOSTIC ERROR; HUMAN; MALE; PHEOCHROMOCYTOMA; TUMOR DIAGNOSIS;

EID: 0032420416     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03348046     Document Type: Article

References (23)

1. Beierwaltes W.H. Update on basic research and clinical experience with metaiodobenzylguanidine. Med. Pediat. Oncol. 15: 163, 1987.
2. Nakajo M., Shapiro B, Sisson J.C., Swanson D.P., Beierwaltes W.H. Salivary gland accumulation of meta-I-131 -iodobenzylguanidine. J. Nucl. Med. 25: 2, 1984.
3. Nakajo M., Shapiro B, Copp J., Kalff V., Gross M.D., Sisson J.C., Beierwaltes W.H. The normal and abnormal distribution of the adrenomedullary imaging agent I-131-iodobenzylguanidine (I-131 MIBG) in man; evaluation of scintigraphy. J. Nucl. Med. 24: 672, 1983.
4. Sisson J., Wieland D. Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies. Am. J. Physiol. Imaging 1: 96, 1986.
5. Hanson M.W., Feldman J.M., Beam C.A., Leight G.S., Coleman R.E. Iodine-131-labeled metaiodobenzylguanidine scintigraphy and biochemical analysis in suspected pheochromocytoma. Arch. Intern. Med. 151: 1397, 1991.
6. Mozley P.D., Kim C.K., Mohsin J., Jatlow A., Gossfield III E., Alavi A. The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma. J. Nucl. Med. 35: 1138, 1994.
7. Ackery D.M., Tippett P.A., Condon B.R., Sutton H.E., Wyeth P. New approach to the localization of pheochromocytoma; imaging with Iodine-131- metaiodobenzylguanidine. Br. Med. J. 288: 1587, 1984.
8. Bravo E.L., Gifford R.W. Pheochromocytoma: diagnosis, localization and management. N. Engl. J. Med. 311: 1298, 1984.
9. Chatal F., Charbonnel B. Comparison of iodobenzylguanidine imaging with computed tomography in locating pheochromocytoma. J. Clin. Endocrinol. Metab. 61: 769, 1985.
10. Velchik M.G., Alavi A., Kressel H.Y., Engelman K. Localization of pheochromocytoma: MIBG, CT and MRI correlation. J. Nucl. Med. 30: 328, 1989.
11. Letizia C., Scavo D. Meta-iodobenzylguanidine seen in the diagnosis of pathologic conditions of the adrenal medulla: pheochromocytoma. Arch. Intern. Med. 150: 1541, 1990.
12. Shapiro B., Copp J.E., Sisson J.C., Eyre P.L., Wallis J., Beierwaltes W.H. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experiences in 400 cases. J. Nucl. Med. 26: 576, 1985.
13. Shapiro B. Summary, conclusions and future directions of 131-I-metaiodobenzylguanidine therapy in the treatment of neural crest tumors. J. Nucl. Biol. Med. 35: 357, 1993.
14. Jacobs A., Lenoir P., Delree M., Ramet J., Piepsz A. Unusual 99m-TC-MDP and 123-MIBG images in focal pyelonephritis. Clin. Nucl. Med. 75: 821, 1990.
15. Hanson M., Feldman J., Beam C., Leight G., Coleman R. Iodine-131-labeled metaiodobenzylguanidine scintigraphy and biochemical analysis in suspected pheochromocytoma. Arch. Intern. Med. 151: 1397, 1991.
16. Feggi L., Uberti E., Pansini G., Transforini G., Prandini N., Ambrosio M., D'urso A., Faggioli R. Pitfalls in scintigraphic detection of neuroendocrine tumors. Eur. J. Nucl. Med. 19: 214, 1992.
17. Gallar P., Oliet A., Hernandez E., Vigil A., Ortege O. Renal failure as a cause of false positive results on metaiodobenzylguanidine scan. Nephrol. Dial. Transplant. 481 (Letter), 1993.
18. Bathmann J., Neumann H., Sigmund G., Moser E. False-positive diagnosis of a pheochromocytoma with I-123 metaiodobenzylguanidine. Clin. Nucl. Med. 19: 221, 1994.
19. Krubsack A., Arnaut M., Hagen T., Zielonka J., Choi H., Akhtar R., Schulte W. Zona fasciculata cortical adenoma and adrenal medullary hyperplasia in MEN II patient: unique concurrent presentation. Clin. Nucl. Med. 13: 730, 1988.
20. Home T., Glaser B., Krausz Y., Rubinger D., Britton K.E. Unusual causes of I-131-metaiodobenzylguanidine uptake in non-neural crest tissue. Clin. Nucl. Med. 16: 239, 1991.
21. Sone H., Okuda Y., Nakamura Y., Ishikawa N., Yamaoka T., Odawara M., Matsushima T., Kawai K, Yamashita K. Radioiodinated metaiodobenzylguanidine scintigraphy for pheochromocytoma: a false-positive case of adrenocortical adenoma and literature review. Horm. Res. 46: 138, 1996.
22. Houghton A., Clarke S., Jourdan M. False-positive diagnosis of adrenal pheochromocytoma on metaiodobenzylguanidine (MIBG) scan. Br. J. Clin. Pharmacol. 44: 411, 1990.
23. Alasabeh R., Mazoujian G., Goates J., Medeiros J., Weiss L.M. Adrenal cortical tumors clinically mimicking pheochromocytoma. Am. J. Clin. Pathol. 104: 382, 1995.